Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Marin Aguilera, M.
~ 3000  Ergebnisse:
Personensuche X
?
1

Cabazitaxel activity and related metabolic changes in RB1 m..:

Marin Aguilera, M. ; Clark, A.K. ; Reig, O....
European Urology Open Science.  32 (2021)  - p. S177 , 2021
Link: https://doi.org/10.1016/..
 
?
2

Molecular changes of circulating tumor cells associated to ..:

Marin Aguilera, M. ; Milà-Guasch, M. ; Jiménez, N....
European Urology Supplements.  17 (2018)  10 - p. e2506 , 2018
Link: https://doi.org/10.1016/..
 
?
3

Analytical validation of HER2DX genomic test for early-stag..:

Marín-Aguilera, M. ; Jares, P. ; Sanfeliu, E....
ESMO Open.  9 (2024)  3 - p. 102903 , 2024
Link: https://doi.org/10.1016/..
 
?
4

74P Assessing the implementation of the HER2DX genomic test..:

Cejalvo, J.M. ; Soberino, J. ; Ciruelos, E.M....
ESMO Open.  9 (2024)  - p. 103080 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Prognostic value of HER2DX in early-stage HER2-positive bre..:

Villacampa, G. ; Pascual, T. ; Brasó-Maristany, F....
ESMO Open.  9 (2024)  3 - p. 102388 , 2024
Link: https://doi.org/10.1016/..
 
?
6

8P First decision impact study of HER2DX in patients (pts) ..:

Saez, O. Martinez ; Brasó-Maristany, F. ; Marín-Aguilera, M....
ESMO Open.  8 (2023)  1 - p. 101232 , 2023
Link: https://doi.org/10.1016/..
 
?
7

5P HER2DX risk-score in HER2-positive (HER2+) breast cancer..:

Saez, O. Martinez ; Brasó-Maristany, F. ; Griguolo, G....
ESMO Open.  8 (2023)  1 - p. 101229 , 2023
Link: https://doi.org/10.1016/..
 
?
8

102P HER2DX risk-score in early-stage HER2-positive (HER2+)..:

Pascual, T. ; Villacampa, G. ; Brasó-Maristany, F....
ESMO Open.  8 (2023)  1 - p. 101326 , 2023
Link: https://doi.org/10.1016/..
 
?
9

13P Analytical validation of HER2DX test for early-hER2+ br..:

Torres, E. Sanfeliu ; Marín-Aguilera, M. ; Jares, P....
ESMO Open.  8 (2023)  1 - p. 101237 , 2023
Link: https://doi.org/10.1016/..
 
?
10

11P Independent validation of the HER2DX assay in HER2-posi..:

Grimalt, B. Fullana ; Brasó-Maristany, F. ; Gómez, N....
ESMO Open.  8 (2023)  1 - p. 101235 , 2023
Link: https://doi.org/10.1016/..
 
?
11

126MO HER2DX and pathological complete response in HER2-pos..:

Waks, A.G. ; Villacampa, G. ; Brunet, L. Pare...
ESMO Open.  8 (2023)  1 - p. 101465 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Different molecular phenotype patterns in cabazitaxel and d..:

Jimenez, N ; Marín-Aguilera, M. ; Reig, Ò....
European Urology Supplements.  17 (2018)  10 - p. e2527 , 2018
Link: https://doi.org/10.1016/..
 
?
13

Different degree of epithelial–mesenchymal transition pheno..:

Jiménez, N. ; Marín-Aguilera, M. ; Reig, O....
European Journal of Cancer.  69 (2016)  - p. S75-S76 , 2016
Link: https://doi.org/10.1016/..
 
?
14

2505 TMPRSS2-ERG in blood and docetaxel response in metasta..:

Reig, O. ; Marín-Aguilera, M. ; Carrera, G....
European Journal of Cancer.  51 (2015)  - p. S475 , 2015
Link: https://doi.org/10.1016/..
 
?
15

693: Intrinsic resistance to sunitinib in clear cell renal ..:

Reig, O. ; Marín-Aguilera, M. ; Lozano, J.J....
European Journal of Cancer.  50 (2014)  - p. S167 , 2014
Link: https://doi.org/10.1016/..
 
1-15